Thrombectomy Device
- UID
- IMP/MD/2019/000486_7a75b2c01ef04d31925d7499de13e71b_ef15ba6d682d8ff9de76745c5c8c104c
- Device class
- Class D
- Brand name
- Aperio® Hybrid Thrombectomy Device
- License holder
- Morulaa Health Tech Pvt Ltd
- Approving authority
- CDSCO
- Product information
- The Aperio® Hybrid Thrombectomy Device is intended for restoration of the arterial flow in patients diagnosed with ischemic stroke due to large intracranial vascular occlusion (Aperio® Hybrid Thrombectomy Device). Patients who fail intravenous thrombolytic therapy or who are ineligible for thrombolysis may be suited for treatment with the Aperio® Hybrid Thrombectomy Device
Thrombectomy Device is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000486_7a75b2c01ef04d31925d7499de13e71b_ef15ba6d682d8ff9de76745c5c8c104c. This device is marketed under the brand name Aperio® Hybrid Thrombectomy Device. The license holder is Morulaa Health Tech Pvt Ltd, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.